ANXA1 and acute myeloid leukemia: Based on the above results in vitro, in vivo, and ex vivo, we proposed a novel molecular mechanism for Notch1 in regulating cell proliferation and a new therapeutic paradigm targeting the ANXA1‐Notch1 signaling of human AML as shown in Figure7.